Effect of a new anticoagulant (MD 805) on platelet activation in the hemodialysis circuit
- 1 January 1986
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 41 (1), 33-41
- https://doi.org/10.1016/0049-3848(86)90277-x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- In vitro studies of a new synthetic thrombin inhibitorThrombosis Research, 1985
- Intra-Platelet Platelet Factor 4 (IP.PF4) and the Heparin-Mobilisable Pool of PF4 in Health and AtherosclerosisThrombosis and Haemostasis, 1984
- Heparin Counteracts the Antiaggregating Effect of Prostacyclin by Potentiating Platelet AggregationThrombosis and Haemostasis, 1983
- Comparative study on heparin and a synthetic thrombin inhibitor no.805 (MD-805) in experimental antithrombin III-deficient animalsThrombosis Research, 1981
- Plasma beta-thromboglobulin and platelet factor 4 in renal failureThrombosis Research, 1981
- THE EFFECTS OF 3 DIFFERENT HEPARIN REGIMES ON HEPARIN CONCENTRATIONS IN PLASMA AND FIBRIN FORMATION IN DIALYZERS1981
- THROMBOSIS AND THROMBOCYTOPENIA INDUCED BY HEPARINScandinavian Journal of Haematology, 1980
- Heparins and ReleaseThrombosis and Haemostasis, 1980
- INHIBITION OF PLATELET-AGGREGATION BY A NEW AGENT, TICLOPIDINE1979
- Whole-blood Clotting Time, Activated Partial Thromboplastin Time, and Whole-blood Recalcification Time as Heparin Monitoring TestsAmerican Journal of Clinical Pathology, 1979